Works matching AU Ando Masashi


Results: 141
    1
    2
    3

    Serum CA19-9 Response Is an Early Predictive Marker of Efficacy of Regorafenib in Refractory Metastatic Colorectal Cancer.

    Published in:
    Oncology, 2017, v. 93, n. 5, p. 329, doi. 10.1159/000479280
    By:
    • Komori, azusa;
    • Taniguchi, Hiroya;
    • Hamauchi, Satoshi;
    • Masuishi, Toshiki;
    • Kito, Yosuke;
    • Narita, Yukiya;
    • Tsushima, Takahiro;
    • Ishihara, Makoto;
    • Todaka, akiko;
    • Tanaka, Tsutomu;
    • Yokota, Tomoya;
    • Kadowaki, Shigenori;
    • Machida, Nozomu;
    • Ura, Takashi;
    • Fukutomi, akira;
    • ando, Masashi;
    • Onozawa, Yusuke;
    • Tajika, Masahiro;
    • Yasui, Hirofumi;
    • Muro, Kei
    Publication type:
    Article
    4
    5
    6
    7
    8
    9

    Safety of a short-term infusion of fosnetupitant in patients with gastrointestinal and breast cancer: a prospective study.

    Published in:
    Oncologist, 2025, v. 30, n. 2, p. 1, doi. 10.1093/oncolo/oyae223
    By:
    • Nakata, Akinobu;
    • Hashimoto, Naoya;
    • Narita, Yukiya;
    • Wakabayashi, Munehiro;
    • Kodama, Hiroyuki;
    • Ogata, Takatsugu;
    • Honda, Kazunori;
    • Masuishi, Toshiki;
    • Taniguchi, Hiroya;
    • Kadowaki, Shigenori;
    • Ando, Masashi;
    • Endo, Yuka;
    • Kotani, Haruru;
    • Kataoka, Ayumi;
    • Hattori, Masaya;
    • Yoshimura, Akiyo;
    • Sawaki, Masataka;
    • Nozawa, Kazuki;
    • Oze, Isao;
    • Iwata, Hiroji
    Publication type:
    Article
    10

    Bevacizumab, Irinotecan, and Biweekly Trifluridine/Tipiracil for Metastatic Colorectal Cancer: MODURATE, a Phase Ib Study.

    Published in:
    Oncologist, 2023, v. 28, n. 11, p. e1108, doi. 10.1093/oncolo/oyad143
    By:
    • Taniguchi, Hiroya;
    • Yamazaki, Kentaro;
    • Masuishi, Toshiki;
    • Kawakami, Takeshi;
    • Onozawa, Yusuke;
    • Honda, Kazunori;
    • Kadowaki, Shigenori;
    • Narita, Yukiya;
    • Tsushima, Takahiro;
    • Hamauchi, Satoshi;
    • Todaka, Akiko;
    • Yokota, Tomoya;
    • Ando, Masashi;
    • Mori, Keita;
    • Shirasu, Hiromichi;
    • Yasui, Hirofumi;
    • Muro, Kei
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    An Analysis of Guidance for Proper Usage Document for Oncology Drugs in Japan.

    Published in:
    Pharmaceutical Medicine, 2012, v. 26, n. 3, p. 165, doi. 10.1007/BF03262390
    By:
    • Yonemori, Kan;
    • Hirakawa, Akihiro;
    • Ryushima, Yasuaki;
    • Saito, Mari;
    • Yamamoto, Harukaze;
    • Hirata, Taizo;
    • Ando, Masashi;
    • Kodaira, Makoto;
    • Yunokawa, Mayu;
    • Shimizu, Chikako;
    • Tamura, Kenji;
    • Yamamoto, Hiroshi;
    • Fujiwara, Yasuhiro
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Efficacy and safety of nivolumab monotherapy in patients with unresectable clear cell sarcoma and alveolar soft part sarcoma (OSCAR Trial/NCCH1510).

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 22, p. 3836, doi. 10.1002/cncr.35483
    By:
    • Nishikawa, Tadaaki;
    • Kakunaga, Shigeki;
    • Tamura, Kenji;
    • Ando, Masashi;
    • Ozaki, Toshifumi;
    • Kawai, Akira;
    • Ueda, Takafumi;
    • Kawasaki, Mamiko;
    • Tomatsuri, Sawako;
    • Okamura, Nobuko;
    • Kamikura, Masahisa;
    • Hamada, Akinobu;
    • Yoshida, Akihiko;
    • Hirakawa, Akihiro;
    • Shibata, Taro;
    • Nakamura, Kenichi;
    • Yonemori, Kan
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50